BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12114426)

  • 1. The expression of carbonic anhydrase II in hematological malignancies.
    Leppilampi M; Koistinen P; Savolainen ER; Hannuksela J; Parkkila AK; Niemelä O; Pastoreková S; Pastorek J; Waheed A; Sly WS; Parkkila S; Rajaniemi H
    Clin Cancer Res; 2002 Jul; 8(7):2240-5. PubMed ID: 12114426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].
    Shi H; Zhu F; Xiao AQ; Zhang ZR; Zhang R
    Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells.
    Guillaume N; Alleaume C; Munfus D; Capiod JC; Touati G; Pautard B; Desablens B; Lefrère JJ; Gouilleux F; Lassoued K; Gouilleux-Gruart V
    Haematologica; 2005 Jul; 90(7):899-905. PubMed ID: 15996927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant.
    Yamamoto M; Nakagawa M; Ichimura N; Ohtsuki F; Ohtsuka Y; Tsujino Y; Tanaka A; Kamiya T; Wada H
    Am J Hematol; 1996 Jul; 52(3):212-4. PubMed ID: 8756090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
    Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
    Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially therapeutically relevant differences of antisense oligonucleotide uptake in CD34+ hematopoietic stem cells, leukemic blasts and cancer cells from patients.
    Seitz G; Kohler G; Nehmzow M; Lorenz G; Denzlinger C; Müller C; Bader P; Brischwein K; Beck JF
    Anticancer Res; 2002; 22(3):1717-9. PubMed ID: 12168859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
    Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
    Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocalyxin: a marker of blasts in acute leukemia.
    Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
    Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
    Thiede Ch; Lutterbeck K; Oelschlägel U; Kiehl M; Steudel Ch; Platzbecker U; Brendel C; Fauser AA; Neubauer A; Ehninger G; Bornhäuser M
    Ann Hematol; 2002; 81 Suppl 2():S27-8. PubMed ID: 12611065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Flotho C; Paulun A; Batz C; Niemeyer CM
    Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.